OXFD
NASDAQOxford Immunotec Global PLC
News25/Ratings0
Latest news
25 items- 13D/GSEC Form SC 13G filed by Oxford Immunotec Global PLCSC 13G - Oxford Immunotec Global PLC (0001586049) (Subject)
- SECSEC Form 15-12B filed by Oxford Immunotec Global PLC15-12B - Oxford Immunotec Global PLC (0001586049) (Filer)
- SECSEC Form S-8 POS filedS-8 POS - Oxford Immunotec Global PLC (0001586049) (Filer)
- INSIDERSEC Form 4: Herm Rosenman disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- INSIDERSEC Form 4: E T Matthew Mclaughlin disposed to the issuer $1,350,954 worth of Ordinary Shares (61,407 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- INSIDERSEC Form 4: A Richard Sandberg disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- INSIDERSEC Form 4: R. Mark Klausner disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- INSIDERSEC Form 4: Patricia Randall disposed to the issuer $611,710 worth of Ordinary Shares (27,805 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- INSIDERSEC Form 4: Louise Janet Kidd disposed to the issuer $246,554 worth of Ordinary Shares (11,207 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- INSIDERSEC Form 4: J Patrick Balthrop disposed to the issuer $177,782 worth of Ordinary Shares (8,081 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- INSIDERSEC Form 4: Scott Andrew Walton disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- INSIDERSEC Form 4: Peter Wrighton-Smith disposed to the issuer $8,804,950 worth of Ordinary Shares (400,225 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- INSIDERSEC Form 4: Asbury Ronald Andrews disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- SECSEC Form S-8 POS filedS-8 POS - Oxford Immunotec Global PLC (0001586049) (Filer)
- INSIDERSEC Form 4: R James Tobin disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units4 - Oxford Immunotec Global PLC (0001586049) (Issuer)
- 13D/GSEC Form SC 13G filedSC 13G - Oxford Immunotec Global PLC (0001586049) (Subject)
- SECSEC Form 8-K filed8-K - Oxford Immunotec Global PLC (0001586049) (Filer)
- SECSEC Form 25-NSE filed25-NSE - Oxford Immunotec Global PLC (0001586049) (Subject)
- PROxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 InfectionOXFORD, United Kingdom and MARLBOROUGH, Mass., March 4, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative detection of a cell mediated (T cell) immune response to SARS-CoV-2 in human whole blood. The company has filed an EUA request to the FDA for the test. T-SPOT®.COVID, a Test from Oxford Immunotec Global PLC for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection Serology does not give the full picture of the adaptive immune response to SARS-CoV-2 infe
- SECSEC Form 8-K/A filed8-K/A - Oxford Immunotec Global PLC (0001586049) (Filer)
- SECSEC Form 8-K filed8-K - Oxford Immunotec Global PLC (0001586049) (Filer)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Oxford Immunotec Global PLC (0001586049) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Oxford Immunotec Global PLC (0001586049) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Oxford Immunotec Global PLC (0001586049) (Subject)
- 13D/GSEC Form SC 13G filedSC 13G - Oxford Immunotec Global PLC (0001586049) (Subject)